J. Popp

Discipline

Psychologie (24)

Type de document

Articles (42) Recensions (4)

Type de document

Articles (1)

Co-auteur

Date

Date

Source

Source

Mot-clé

Alzheimer's disease (31) Amyloid (26) Dementia (25) Biochemical markers (24) Cerebrospinal fluid (23) pathologie (22) biomarqueur (22) Pathology (22) Human beings (22) Older people (22) Cognition (21) maladie (20) âge (20) Age (20) Age (20) maladie (20) Mild cognitive impairment (17) Patients (16) Disabilities (16) Patients (16) risque (14) Risk (14) association (13) Apolipoprotein E (13) Social groups (13) Proteins (13) Performance (13) Performance (13) cohorte (13) protéine (12)

Mot-clé

Allemagne (1) Characters (1) Speeches, addresses, etc (1) Point of view (Literature) (1) Technique (1) Relations (1) Discursos (1) Technique (1) Personnages (1) Relations (1) Point de vue (littérature) (1) Discours (1) Technique (1) technologie (1) discours (1) relations (1) Allemagne (1)

Documents écrit par J. Popp (42) | parle de J. Popp (1)

Multiomics profiling of human plasma and cerebrospinal fluid reveals ATN-derived networks and highlights causal links in Alzheimer's disease.
L. Shi et al.
Whole-exome rare-variant analysis of Alzheimer's disease and related biomarker traits.
F. Küçükali et al.
Obstructive sleep apnoea and 5-year cognitive decline in the elderly.
N.A. Marchi et al.
Biomarqueurs des pathologies neurodégénératives dans le diagnostic des troubles cognitifs - Revue et recommandations de Swiss Memory Clinics [Biomarkers for the diagnosis of cognitive impairment - Recommendations from the Swiss Memory Clinics]
J. Popp et al. (14 déc. 2022)
Recommandations pour la prévention, le diagnostic et la thérapie des addictions à l’âge avancé [Recommendations for the prevention, diagnosis, and therapy of addiction in the elderly]
J. Popp et al. (28 sept. 2022)
Cerebrospinal fluid proteomic profiling of individuals with mild cognitive impairment and suspected non-Alzheimer's disease pathophysiology.
A. Delvenne et al. (14 juin 2022)
Systemic and central nervous system neuroinflammatory signatures of neuropsychiatric symptoms and related cognitive decline in older people.
C. Clark et al. (28 mai 2022)
Cerebrospinal Fluid Cortisol and Dehydroepiandrosterone Sulfate, Alzheimer's Disease Pathology, and Cognitive Decline.
S. Ouanes et al. (2022)
CSF Proteomic Alzheimer's Disease-Predictive Subtypes in Cognitively Intact Amyloid Negative Individuals.
B.M. Tijms et al. (2 août 2021)
Common variants in Alzheimer's disease and risk stratification by polygenic risk scores.
I. de Rojas et al. (7 juin 2021)
An integrative multi-omics approach reveals new central nervous system pathway alterations in Alzheimer's disease.
C. Clark et al. (1 avr. 2021)
Plasma neurofilament light and phosphorylated tau 181 as biomarkers of Alzheimer's disease pathology and clinical disease progression.
C. Clark et al. (25 mars 2021)
Empfehlungen für die Diagnostik und Therapie psychotischer Erkrankungen im Alter [Recommendations for the Diagnosis and Therapy of Psychotic Disorders in the Elderly]
S. Klöppel et al. (2021)
Plasma Proteomic Biomarkers Relating to Alzheimer's Disease: A Meta-Analysis Based on Our Own Studies.
L. Shi et al. (2021)
Pathophysiological subtypes of Alzheimer's disease based on cerebrospinal fluid proteomics.
B.M. Tijms et al. (1 déc. 2020)
Conference report: dementia research and care and its impact in Switzerland.
T. Leyhe et al. (30 nov. 2020)
Genome-wide association study of Alzheimer's disease CSF biomarkers in the EMIF-AD Multimodal Biomarker Discovery dataset.
S. Hong et al. (22 nov. 2020)
Preoperative Cognitive Impairment and Postoperative Delirium Predict Decline in Activities of Daily Living after Cardiac Surgery-A Prospective, Observational Cohort Study.
U. Guenther et al. (3 oct. 2020)
PLCG2 protective variant p.P522R modulates tau pathology and disease progression in patients with mild cognitive impairment.
L. Kleineidam et al.
APOE ε4 genotype-dependent cerebrospinal fluid proteomic signatures in Alzheimer's disease.
E. Konijnenberg et al. (27 mai 2020)
Key role of MIF-related neuroinflammation in neurodegeneration and cognitive impairment in Alzheimer's disease.
E. Nasiri et al. (17 avr. 2020)
Validation of Plasma Proteomic Biomarkers Relating to Brain Amyloid Burden in the EMIF-Alzheimer's Disease Multimodal Biomarker Discovery Cohort.
S. Westwood et al. (2020)
Dickkopf-1 Overexpression in vitro Nominates Candidate Blood Biomarkers Relating to Alzheimer's Disease Pathology.
L. Shi et al. (2020)
Discovery and validation of plasma proteomic biomarkers relating to brain amyloid burden by SOMAscan assay.
L. Shi et al.
Primary fatty amides in plasma associated with brain amyloid burden, hippocampal volume, and memory in the European Medical Information Framework for Alzheimer's Disease biomarker discovery cohort.
M. Kim et al.

next
Formes du discours et modes de relations des personnages : la perspective narrative dans «Mutmaßungen über Jakob» de Uwe Johnson
Elisabeth Arbogast (1976)